Mohamed El-Naggar

5PUBLICATIONS
15CO-AUTHORS
Biomolecular modelling and designCheminformatics and quantitative structure-activity relationshipsBiologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Aug 27, 2026
1-Butylindoline-2,3-dione derivatives as potent VEGFR-2 inhibitors: synthesis, mechanistic anticancer studies, and molecular dynamics simulations.

|Apr 02, 2026
Design, Synthesis, In Silico Profiling, and In Vitro Anticancer Assessment of Azine-Linked Thiazolo[3,2-a]benzimidazoles as CDK2-Directed Therapeutic Candidates.

Mohamed S M Ahmed, Sayed M Riyadh, Mohammad Alhilal

|Jun 30, 2025
Design, Synthesis, Antimicrobial Evaluation, and In Silico Insights of Novel Thiazole-Based Benzylidene Thiazolidinones as Gyrase Inhibitors.

Saad Alqarni, Magdi E A Zaki, Awatif H Alruwaili

|Dec 17, 2024
Evaluation of Quinazolin-2,4-Dione Derivatives as Promising Antibacterial Agents: Synthesis, In Vitro, In Silico ADMET and Molecular Docking Approaches.

Aboubakr H Abdelmonsef, Mohamed El-Naggar, Amal O A Ibrahim

|Sep 10, 2021
New Amino Acid Schiff Bases as Anticancer Agents via Potential Mitochondrial Complex I-Associated Hexokinase Inhibition and Targeting AMP-Protein Kinases/mTOR Signaling Pathway.

Ahmed A Noser, Aboubakr H Abdelmonsef, Mohamed El-Naggar

Pageof 1

Frequent Collaborators

2 joint publications

Aboubakr H Abdelmonsef

2 joint publications

Magdi E A Zaki

1 joint publications

Ahmed A Noser

1 joint publications

Maha M Salem